Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006

被引:58
|
作者
Trotter, Caroline L. [1 ]
Waight, Pauline [2 ]
Andrews, Nick J. [3 ]
Slack, Mary [4 ]
Efstratiou, Androulla [4 ]
George, Robert [4 ]
Miller, Elizabeth [2 ]
机构
[1] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England
[2] Ctr Infect, Hlth Protect Agcy, Immunisat Dept, London, England
[3] Ctr Infect, Hlth Protect Agcy, Stat Modelling & Econ Dept, London, England
[4] Ctr Infect, Hlth Protect Agcy, Resp & Syst Infect Lab, London, England
基金
美国国家卫生研究院;
关键词
Streptococcus pneumoniae; Invasive pneumococcal disease; Epidemiology; Meningitis; STREPTOCOCCUS-PNEUMONIAE; CHILDREN; ADULTS;
D O I
10.1016/j.jinf.2009.12.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To describe the epidemiology of invasive pneumococcal disease (IPD) in England & Wales in the pre-conjugate vaccine era. Methods: We analysed reports of culture-confirmed IPD submitted to the national surveillance system between July 1996 and June 2006. Results: The incidence of IPD was 10 per 100,000 overall, and increased over time. The typical pattern of IPD by age was observed, with the highest incidence in young children and older adults. There was little change in IPD incidence in the elderly, despite the widespread use of 23-valent pneumococcal polysaccharide vaccines since 2003. The distribution of serotypes changed over time; notably the proportion of cases caused by serotype 14 decreased, and the proportion due to serotype 1 increased. The incidence of meningitis was 0.6 per 100,000 overall, and as a proportion of all IPD cases was most common in children under 1 year of age (30%). Particular serotypes were significantly associated with a presentation of meningitis, after controlling for age and year, and the case: carrier ratio varied markedly by serotype. Conclusions: This paper provides a baseline for evaluating the impact of 7-valent pneumococcal conjugate vaccines, introduced in September 2006. Ongoing high-quality laboratory-based surveillance of IPD in all age groups is essential. (C) 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:200 / 208
页数:9
相关论文
共 50 条
  • [41] Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial
    Palmu, Arto A.
    Jokinen, Jukka
    Nieminen, Heta
    Rinta-Kokko, Hanna
    Ruokokoski, Esa
    Puumalainen, Taneli
    Moreira, Marta
    Schuerman, Lode
    Borys, Dorota
    Kilpi, Terhi M.
    VACCINE, 2018, 36 (14) : 1816 - 1822
  • [42] Molecular epidemiology of Streptococcus pneumoniae isolated from pediatric community-acquired pneumonia in pre-conjugate vaccine era in Western China
    Liang, Zhuoxin
    Fu, Jinjian
    Li, Ling
    Yi, Rongsong
    Xu, Shaolin
    Chen, Jichang
    Ye, Xiaohua
    McGrath, Eric
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2021, 20 (01)
  • [43] Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006
    Abrams, Joseph Y.
    Weintraub, Eric S.
    Baggs, James M.
    McCarthy, Natalie L.
    Schonberger, Lawrence B.
    Lee, Grace M.
    Klein, Nicola P.
    Belongia, Edward A.
    Jackson, Michael L.
    Naleway, Allison L.
    Nordin, James D.
    Hambidge, Simon J.
    Belay, Ermias D.
    VACCINE, 2015, 33 (02) : 382 - 387
  • [44] Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales
    Andrews, Nick J.
    Waight, Pauline A.
    George, Robert C.
    Slack, Mary P. E.
    Miller, Elizabeth
    VACCINE, 2012, 30 (48) : 6802 - 6808
  • [45] The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital Through the 7-valent Pneumococcal Conjugate Vaccine Era A Case for Continuous Surveillance
    Ampofo, Krow
    Pavia, Andrew T.
    Stockmann, Chris
    Hersh, Adam L.
    Bender, Jeffrey M.
    Blaschke, Anne J.
    Weng, Hsin Yi Cindy
    Korgenski, Kent E.
    Daly, Judy
    Mason, Edward O.
    Byington, Carrie L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (03) : 228 - 234
  • [46] Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7-valent pneumococcal conjugate vaccine
    Williams, Scott R.
    Mernagh, Paul J.
    Lee, Michael H. T.
    Tan, Jonathan T.
    MEDICAL JOURNAL OF AUSTRALIA, 2011, 194 (03) : 116 - 120
  • [47] Molecular epidemiology of Streptococcus pneumoniae isolated from pediatric community-acquired pneumonia in pre-conjugate vaccine era in Western China
    Zhuoxin Liang
    Jinjian Fu
    Ling Li
    Rongsong Yi
    Shaolin Xu
    Jichang Chen
    Xiaohua Ye
    Eric McGrath
    Annals of Clinical Microbiology and Antimicrobials, 20
  • [48] Invasive group B streptococcus (GBS) disease in Norway 1996-2006
    Bergseng, H.
    Rygg, M.
    Bevanger, L.
    Bergh, K.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (12) : 1193 - 1199
  • [49] Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines
    Tan, Tina Q.
    CLINICAL MICROBIOLOGY REVIEWS, 2012, 25 (03) : 409 - 419
  • [50] Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan
    Chi, Hsiao-Chun
    Hsieh, Yu-Chia
    Tsai, Ming-Han
    Lee, Chen-Hsiang
    Kuo, Kuang-Che
    Huang, Ching-Tai
    Huang, Yhu-Chering
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (03) : 332 - 336